- International Practice
- Real Estate and Projects
- Broker-Dealer and Market Regulation
- Financial Institutions
- Labor and Employment
- Securities Regulation
- Climate Change
- Financial Restructuring
- Strategic Communications
- Corporate and Securities
- Private Client Services
- Educational Institutions
- Intellectual Property
- Private Funds
- Internal Investigations
- Public Finance
- White Collar Defense
- Environmental Strategies
Shot Down by the Gunn: The Supreme Court Rules in Favor of Leaving Malpractice Cases Involving Underlying Patent Issues with State Courts
February 22, 2013
On February 20, 2013, the Supreme Court issued its opinion in the case of Gunn v. Minton.1 The heart of this matter is whether the state-based malpractice action based upon an underlying patent infringement lawsuit may be heard in state court or whether it must be heard in federal court because it "arises under" federal question jurisdiction. Our previous reports have examined the history of the case as it has moved through the Texas courts to the Supreme Court, including Petitioners' and Respondent's briefs, associated amicus curiae briefs and the oral argument before the Court.2
In summary, the Court found in its 9-0 decision that the Respondent, the inventor Vernon Minton, failed to establish "arising under" subject matter jurisdiction based upon Section 1338(a) for the Texas professional malpractice action against Jerry Gunn and several law firms. Chief Justice Roberts delivered the unanimous opinion of the Court.3
The Court acknowledges that a "special and small category" of cases can arise under federal jurisdiction even when federal law does not create original jurisdiction.4 To determine if this is one of those cases, the case needs to raise a federal issue that is necessary, actually disputed, substantial, and capable of resolution in federal court without disrupting the federal-state balance approved by Congress. In addition, upon meeting these four conditions, consideration is given to Congress' intended division of labor between the state and federal courts.5
In analyzing the state-based malpractice action with an underlying patent infringement suit versus the Grable factors, the Court states that "we are comfortable concluding that state legal malpractice claims based on underlying patent matters will rarely, if ever, arise under federal patent law for purposes of §1338(a)."6
After passing quickly through the first two Grable elements – necessary and disputed – the Court addresses the element of "substantiality" of the issue presented. The Court identifies problems not only with the Texas Supreme Court's analysis of substantiality in Minton but also the analysis of the Federal Circuit in the opinion from Air Measurement:7
As our past cases show, however, it is not enough that the federal issue be significant to the particular parties in the immediate suit; that will always be true when the state claim "necessarily raise[s]" a disputed federal issue, as Grable separately requires. The substantiality inquiry under Grable looks instead to the importance of the issue to the federal system as a whole.8
The Court turns to Grable and Smith9 and further differentiates this case in showing that the importance of the question to the parties alone is not enough – it must be important to the validity of the government's action or the law.10
In addition, the hypothetical nature of the causation element of a malpractice action – the case-within-a-case or suit-within-a-suit – simply does not make the patent infringement or patent prosecution issue substantial. "No matter how the state courts resolve that hypothetical 'case within a case,' it will not change the real-world result of the prior federal patent litigation. Minton's patent will remain invalid."11 The Court expressed reassurance that non-hypothetical patent cases have original and exclusive jurisdiction in federal courts under 28 U.S.C. § 1338(a), and if any novel question emerges from the state-based case-within-a-case analysis that the question would eventually be settled by a federal court.12
In regards to the expertise given in federal courts and administrative agencies towards patents, the Court simply did not find the argument that their mere existence endowed patent legal issues in this hypothetical context with substantiality. The Court expressed its full confidence that state courts can handle the interpretation of patent law for non-federal issues: "[b]ut the possibility that a state court will incorrectly resolve a state claim is not, by itself, enough to trigger the federal courts' exclusive patent jurisdiction, even if the potential error finds its root in a misunderstanding of patent law."13
The Court also cites to the critical role that states play in administrating their attorneys, acknowledging the special burden that states play in maintaining the professional standards of their members. The Court was not presented with a reason that would undermine this critical state function, especially in light that the patent issue is only a hypothetical one.14
In concluding, the Court found that any decision of the patent matter in Gunn would not have a broad effect, and therefore the issue simply did not necessitate federal court intervention.15
The effects of the decision
The immediate effect for Jerry Gunn and the other Petitioners is that the malpractice case against them is effectively over after 9 years.16 Upon remand, the Texas Supreme Court will likely adopt the decision originally given in Minton at the Ft. Worth Court of Appeals, which found a lack of substantially and a conflict with the federal/state balance.17
The Gunn opinion effectively overturns both Air Measurement and Immunocept,18 the Federal Circuit's version of the Grable test, and validates the opinions given in New Tek I & II,19 which are from the Nebraska Supreme Court in 2005 and 2008 that assert state dominion over malpractice actions even in the light of an underlying patent issue. The Court cited Air Measurement several times and indicated what the proper substantiality and federal/state balance analysis should have been.20 The Grable analysis given in both Air Measurement and Immunocept have been used in dozens of other suits since 2007, both in state and federal courts, to remove patent malpractice cases from the state courts and to prevent remand back to state court.21 Any current use of Minton and Air Measurement in non-patent related cases will likely be immediately challenged.22
The Supreme Court's opinion also vindicates the dissenting and concurring opinions given by Justice Kathleen O'Malley in the spring of 2012. Justice O'Malley's dissenting opinion for the denial of en banc rehearing in Byrne23 and her concurring and dissenting opinions in several other patent malpractice cases that quickly followed24 provided the most salient arguments – that there is a problem with the Federal Circuit's analysis of substantiality and the federal/state balance – for Petitioner Gunn. It is now likely that Byrne, which is on petition for certiorari with the Court,25 will likely be remanded back to the Federal Circuit with instructions to follow the decision as presented in Gunn.
The Supreme Court's decision in Gunn is available at the Court's website.26
If your company has questions about, or cases involving, "arising under" jurisdiction, please contact any of the Bracewell & Giuliani attorneys listed for more information regarding this topic.
2 Mike Sellers et al., Gunning for the Supreme Court: A "Substantial" Case "Arising" from Texas That Means More Than You Think! (Oct. 9, 2012), available here; Mike Sellers et al., Opening Shots in Gunn v. Minton: The Petitioner's Brief and Several Amici Curiae Briefs in Support (Dec. 27, 2012), available here; Mike Sellers, et al., Returning Fire: The Respondent's Brief and Several Supporting Amicus Curiae Briefs in Gunn v. Minton (Jan. 10, 2013), available here; Terrorizing Patent Practitioners: Highlights from Oral Argument at the Supreme Court for Gunn v. Minton (Feb. 5, 2013), available here.
3 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 1.
4 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 5-6 (quoting from Empire HealthChoice Assurance, Inc. v. McVeigh, 547 U.S. 677, 699 (2006)).
5 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 5-6 (citing to Grable & Sons Metal Products, Inc. v. Darue Eng. & Manuf., 545 U.S. 308, 314 (2005)).
6 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 6-7.
7 Air Measurement Tech., Inc. v. Akin Gump Strauss Hauer & Feld, LLP, 504 F.3d 1262 (Fed. Cir. 2007);
8 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 8 (emphasis added).
9 Smith v. Kansas City Title & Trust Co., 255 U.S. 180 (1921) (challenge to constitutional validity of federally-issued bonds).
10 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 9.
12 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 10.
13 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 11-12.
14 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 12.
15 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 13.
16 See Minton v. Gunn, No. 048-207288-04 (48th Dist. Ct., Tarrant Co., Tex. Sep. 19, 2006) (Order) (suit filed in 2004).
17 See Minton v. Gunn, 301 S.W.3d 702, 708-10 (Tex. App. - Fort Worth 2009), rev'd, 355 S.W.3d 634 (Tex. 2011).
18 See Immunocept, LLC v. Fulbright & Jaworski, LLP, 504 F.3d 1281 (Fed. Cir. 2007).
19 See New Tek Manuf. v. Beehner, 270 N.W.2d 336 (Neb. 2005) ["New Tek I"] (hypothetical patent issue do not provoke exclusive federal patent jurisdiction); New Tek Manuf. v. Beehner, 751 N.W.2d 135 (Neb. 2008) ["New Tek II"] (Air Measurement and Immunocept do not change court's analysis).
20 Gunn, 568 U.S. ___, No. 11-1118, slip op. at 4, 8 and 11-12.
21 See, e.g., Warrior Sports v. Dickinson Wright, P.L.L.C., 631 F.3d 1367 (Fed. Cir.), vacating and remanding 632 F. Supp.2d 694 (E.D. Mich 2009) (finding no federal standing under Grable for malpractice action on a lapsed patent); Landmark Screens, LLC v. Morgan, Lewis & Bockius, LLP, 107 Cal. Rptr. 3d 373 (Cal. App. 6th Dist. 2010) (dismissed malpractice claims based upon failure to file a divisional application using Air Measurement analysis).
22 See, e.g., Reserve Management Co. v. Willkie Farr & Gallagher LLP, No. 11 Civ. 7045 (PGC, S.D.N.Y. Sept. 25, 2012) (professional negligence in for advice to an investment management company, citing to Minton).
23 Byrne v. Wood, Herron & Evans, LLP, 676 F.3d 1024, 1027-41 (per curiam) (Fed. Cir. 2012) (denial of en banc rehearing) (O'Malley, J., dissenting).
24 Memorylink Corp. v. Motorola, Inc., 676 F.3d 1051 (Fed. Cir. 2012) (denial of petition for reh'r en banc) (O'Malley, dissenting); USPPS, Ltd. v. Avery Dennison Corp., 676 F.3d 1341 (Fed. Cir. 2012) (per curium) (O'Malley, concurring); Landmark Screens, LLC v. Morgan, Lewis, & Bockius, LLP, 676 F.3d 1354 (Fed. Cir. 2012) (O'Malley, concurring); Minkin v. Gibbons, P.C., 680 F.3d 1341 (Fed. Cir. 2012) (O'Malley, concurring).
25 Byrne v. Wood, Herron & Evans, LLP, 676 F.3d 1024 (Fed. Cir. 2012), petition for cert. filed (U.S. June 8, 2012) (No. 11-1497).